The "What's Broke" Method for Psychiatric Pharmacology

Bipolar Disorder

Bipolar disorder involves a disruption of circadian rhythms and mood stability. Treatment focuses on Mood Stabilizers and atypical antipsychotics to prevent mania (characterized by increased energy and grandiosity).

• Lithium: A cornerstone of treatment, but it has a narrow therapeutic index, meaning the window between a therapeutic dose and a toxic dose is very small.
• Valproate: Effective for mood stabilization but requires monitoring for hepatic (liver) issues and carries significant teratogenic risks (risk of birth defects).

Exam Tip: When treating a patient with Bipolar Disorder, always assess for a history of mania before prescribing an antidepressant, as antidepressants can trigger a manic episode in Bipolar I patients.

Anxiety and OCD: The Fear Circuits

In anxiety disorders, the "break" is often found in the hyperactivity of the amygdala and fear circuits. For Obsessive-Compulsive Disorder (OCD), the disruption lies in the hyperactivity of the cortico-striatal-thalamo-cortical circuits.

• Benzodiazepines: These enhance the inhibitory neurotransmitter GABA to provide rapid anxiolysis. However, they carry high risks of sedation, respiratory depression, and dependence.
• Buspirone: A 5-HT1A partial agonist used for anxiety; it has minimal side effects but requires at least one week to become effective.
• High-dose SSRIs: Often required to manage the intense symptoms of OCD.

Neurodevelopmental Disorders: ADHD, Autism, and Tics

ADHD

The pathophysiology of ADHD involves underactivity in the prefrontal cortex and basal ganglia, specifically regarding dopamine and norepinephrine.

• Stimulants: The first-line treatment, which increases dopamine and norepinephrine. Side effects include increased heart rate, insomnia, and appetite loss.
• Atomoxetine: A non-stimulant norepinephrine reuptake inhibitor. It may cause GI upset and liver toxicity.

Autism and Tic Disorders

Autism Spectrum Disorder is characterized by altered neural connectivity affecting social communication. Tic Disorders stem from the dysregulation of motor and vocal circuits in the basal ganglia. While management often focuses on behavioral therapy, antipsychotics may be used to manage symptoms, though they require careful monitoring for extrapyramidal symptoms (EPS).

Substance Use Disorders: Restoring Balance

Alcohol Use Disorder (AUD)

The "break" in AUD involves a neuroadaptation between the inhibitory GABA system and the excitatory Glutamate system. Chronic use leads to tolerance and dangerous withdrawal symptoms like tremors, seizures, or Delirium Tremens (DTs).

• Benzodiazepines: Used to manage acute withdrawal by mimicking GABA.
• Naltrexone: Used to reduce cravings.
• Thiamine: Essential to prevent Wernicke’s encephalopathy in patients with chronic alcohol use.

Opioid Use Disorder (OUD)

OUD disrupts the endogenous opioid system, leading to profound dopamine-driven dependence.

• Methadone: A full opioid agonist used for maintenance.
• Buprenorphine: A partial agonist that helps stabilize the patient.
• Naltrexone: An antagonist used to block the effects of opioids.
• Naloxone: A critical emergency antagonist used to reverse an active opioid overdose.

Critical Safety: The "Must-Not-Miss" Items

Regardless of the diagnosis, safety monitoring is the most vital part of the framework.

1. Metabolic Syndrome: Common with antipsychotic use; monitor weight, lipids, and glucose.
2. Extrapyramidal Symptoms (EPS): Movement disorders caused by dopamine blockade.
3. QTc Prolongation: A heart rhythm risk associated with many psychotropic medications.
4. Neuroleptic Malignant Syndrome (NMS): A life-threatening emergency associated with antipsychotics. If suspected, stop the medication immediately and provide intensive care.

Clinical Pearl: The best medication is the one that fixes the underlying problem without creating a new, more dangerous one.